NeoCore Technology Co., Ltd. (TPEX:4131)
39.40
-0.65 (-1.62%)
Jan 22, 2026, 11:43 AM CST
NeoCore Technology Market Cap
NeoCore Technology has a market cap or net worth of 1.58 billion as of January 21, 2026. Its market cap has increased by 35.76% in one year.
Market Cap
1.58B
Enterprise Value
1.64B
Revenue
190.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.40
Market Cap Chart
Since November 3, 2004, NeoCore Technology's market cap has increased from 15.79M to 1.58B, an increase of 9,915.70%. That is a compound annual growth rate of 24.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.58B | -4.64% |
| Dec 31, 2025 | 1.66B | 31.25% |
| Dec 31, 2024 | 1.26B | 45.45% |
| Dec 29, 2023 | 869.00M | 123.11% |
| Dec 26, 2022 | 389.50M | 24.09% |
| Dec 28, 2021 | 313.90M | 1.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TWi Biotechnology | 2.21B |
| Chunghwa Chemical Synthesis & Biotech | 2.00B |
| Great Novel Therapeutics Biotech & Medicals | 1.84B |
| Genomics BioSci & Tech. | 1.81B |
| Advagene Biopharma | 1.56B |
| GenMont Biotech Incorporation | 1.55B |
| Enimmune corporation | 1.51B |
| Abnova (Taiwan) | 1.47B |